OpenURL Connection Search

Select item for more details and to access through your institution.

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1077768
By:
- Junqiang Lv;
- Hao Sun;
- Lixin Gong;
- Xiaojing Wei;
- Yi He;
- Zhen Yu;
- Lanting Liu;
- Shuhua Yi;
- Weiwei Sui;
- Yan Xu;
- Shuhui Deng;
- Gang An;
- Zhi Yao;
- Lugui Qiu;
- Mu Hao
Publication type:
Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
Published in:
Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0164-4
By:
- Sidan Li;
- Dehui Zou;
- Changhong Li;
- Hengxing Meng;
- Weiwei Sui;
- Sizhou Feng;
- Tao Cheng;
- Qiongli Zhai;
- Lugui Qiu
Publication type:
Article
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.
Published in:
Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221340
By:
- Cui, Jian;
- Yu, Tengteng;
- Lv, Rui;
- Liu, Jiahui;
- Fan, Huishou;
- Yan, Wenqiang;
- Xu, Jingyu;
- Du, Chenxing;
- Deng, Shuhui;
- Sui, Weiwei;
- Ho, Matthew;
- Xu, Yan;
- Anderson, Kenneth C.;
- Dong, Xifeng;
- Qiu, Lugui;
- An, Gang
Publication type:
Article
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
Published in:
British Journal of Haematology, 2021, v. 194, n. 5, p. 862, doi. 10.1111/bjh.17703
By:
- Lyu, Rui;
- Wang, Tingyu;
- Wang, Yi;
- Xiong, Wenjie;
- Wang, Huijun;
- Yan, Yuting;
- Wang, Qi;
- Liu, Wei;
- An, Gang;
- Huang, Wenyang;
- Sui, Weiwei;
- Xu, Yan;
- Zou, Dehui;
- Wang, Jianxiang;
- Qiu, Lugui;
- Yi, Shuhua
Publication type:
Article
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
Published in:
Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03798-6
By:
- Sun, Hao;
- Fang, Teng;
- Wang, Tingyu;
- Yu, Zhen;
- Gong, Lixin;
- Wei, Xiaojing;
- Wang, Huijun;
- He, Yi;
- Liu, Lanting;
- Yan, Yuting;
- Sui, Weiwei;
- Xu, Yan;
- Yi, Shuhua;
- Qiu, Lugui;
- Hao, Mu
Publication type:
Article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Published in:
American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
By:
- Mao, Xuehan;
- Yan, Wenqiang;
- Mery, David;
- Liu, Jiahui;
- Fan, Huishou;
- Xu, Jingyu;
- Xu, Yan;
- Sui, Weiwei;
- Deng, Shuhui;
- Zou, Dehui;
- Du, Chenxing;
- Yi, Shuhua;
- van Rhee, Frits;
- Barlogie, Bart;
- Shaughnessy, John D.;
- Anderson, Kenneth C.;
- Zhan, Fenghuang;
- Qiu, Lugui;
- An, Gang
Publication type:
Article
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
Published in:
Annals of Hematology, 2024, v. 103, n. 4, p. 1305, doi. 10.1007/s00277-023-05573-z
By:
- Shi, Lihui;
- Yan, Wenqiang;
- Xu, Jingyu;
- Li, Lingna;
- Cui, Jian;
- Liu, Yuntong;
- Du, Chenxing;
- Yu, Tengteng;
- Zhang, Shuaishuai;
- Sui, Weiwei;
- Deng, Shuhui;
- Xu, Yan;
- Zou, Dehui;
- Wang, Huijun;
- Qiu, Lugui;
- An, Gang
Publication type:
Article
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.
Published in:
Annals of Hematology, 2024, v. 103, n. 1, p. 339, doi. 10.1007/s00277-023-05465-2
By:
- Yan, Wenqiang;
- Lv, Rui;
- Xu, Jingyu;
- Li, Lingna;
- Cui, Jian;
- Liu, Yuntong;
- Du, Chenxing;
- Song, Yanyan;
- Sui, Weiwei;
- Deng, Shuhui;
- Xu, Yan;
- Yi, Shuhua;
- Zou, Dehui;
- Qiu, Lugui;
- Li, Wenjun;
- An, Gang
Publication type:
Article
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation.
Published in:
Annals of Hematology, 2023, v. 102, n. 11, p. 3195, doi. 10.1007/s00277-023-05427-8
By:
- Xu, Jingyu;
- Yan, Wenqiang;
- Fan, Huishou;
- Liu, Jiahui;
- Li, Lingna;
- Du, Chenxing;
- Deng, Shuhui;
- Sui, Weiwei;
- Xu, Yan;
- Qiu, Lugui;
- An, Gang
Publication type:
Article
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
Published in:
Annals of Hematology, 2022, v. 101, n. 6, p. 1201, doi. 10.1007/s00277-022-04795-x
By:
- Wang, Yi;
- Wang, Tingyu;
- Yu, Ying;
- Wang, Qi;
- Yan, Yuting;
- Li, Ru;
- Sun, Qi;
- Xiong, Wenjie;
- Lyu, Rui;
- Yu, Zhen;
- Liu, Wei;
- Sui, Weiwei;
- Huang, Wenyang;
- Wang, Huijun;
- Li, Chengwen;
- Wang, Jun;
- Zou, Dehui;
- An, Gang;
- Wang, Jianxiang;
- Qiu, Lugui
Publication type:
Article
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
Published in:
Annals of Hematology, 2015, v. 94, n. 2, p. 257, doi. 10.1007/s00277-014-2211-0
By:
- An, Gang;
- Qin, Xiaoqi;
- Acharya, Chirag;
- Xu, Yan;
- Deng, Shuhui;
- Shi, Lihui;
- Zang, Meirong;
- Sui, Weiwei;
- Yi, Shuhua;
- Li, Zengjun;
- Hao, Mu;
- Feng, Xiaoyan;
- Jin, Fengyan;
- Zou, Dehui;
- Qi, Junyuan;
- Zhao, Yaozhong;
- Tai, Yu-Tzu;
- Wang, Jianxing;
- Qiu, Lugui
Publication type:
Article
Gemcitabine‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes.
Published in:
Cancer Medicine, 2024, v. 13, n. 2, p. 1, doi. 10.1002/cam4.6965
By:
- Liu, Huimin;
- Zou, Hesong;
- Shan, Dandan;
- Liu, Wei;
- Huang, Wenyang;
- Sui, Weiwei;
- Deng, Shuhui;
- Wang, Tingyu;
- Lv, Rui;
- Fu, Mingwei;
- Xu, Yan;
- Yi, Shuhua;
- An, Gang;
- Zhao, Yaozhong;
- Qiu, Lugui;
- Zou, Dehui
Publication type:
Article
Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment.
Published in:
Clinical & Translational Medicine, 2023, v. 13, n. 1, p. 1, doi. 10.1002/ctm2.1140
By:
- Wei, Xiaojing;
- Yu, Zhen;
- Tang, Peixia;
- Sun, Hao;
- Gong, Lixin;
- Liu, Lanting;
- Fang, Teng;
- He, Yi;
- Wang, Tingyu;
- Sui, Weiwei;
- Xu, Yan;
- An, Gang;
- Xu, Zhenshu;
- Ma, Xiaoke;
- Qiu, Lugui;
- Hao, Mu
Publication type:
Article
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1184395
By:
- Yuting Yan;
- Rui Lv;
- Tingyu Wang;
- Ying Yu;
- Yanshan Huang;
- Wenjie Xiong;
- Yuxi Li;
- Weiwei Sui;
- Qi Wang;
- Wenyang Huang;
- Gang An;
- Dehui Zou;
- Jianxiang Wang;
- Lugui Qiu;
- Shuhua Yi
Publication type:
Article
Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171539
By:
- Wenjie Xiong;
- Zanzan Wang;
- Tingyu Wang;
- Ying Yu;
- Yanshan Huang;
- Hao Sun;
- Jiawen Chen;
- Rui Lyu;
- Huijun Wang;
- Yuting Yan;
- Qi Wang;
- Wei Liu;
- Gang An;
- Weiwei Sui;
- Wenyang Huang;
- Dehui Zou;
- Zhijian Xiao;
- Jianxiang Wang;
- Guifang Ouyang;
- Lugui Qiu
Publication type:
Article
P-174: Clinical study of bortezomib-based regimens of BCD, PAD and VDD for newly diagnosed multiple myeloma – an analysis of 400 cases in a single center of China.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S131, doi. 10.1016/S2152-2650(21)02301-6
By:
- Shuhui Deng;
- Yan Xu;
- Weiwei Sui;
- Dehui Zou;
- Gang An;
- Lugui Qiu
Publication type:
Article
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
Published in:
2020
By:
- Yan, Yuting;
- Lv, Rui;
- Xiong, Wenjie;
- Li, Zengjun;
- Wang, Yi;
- Yu, Ying;
- Yu, Zhen;
- Wang, Tingyu;
- Sui, Weiwei;
- Liu, Wei;
- Zou, Dehui;
- Yi, Shuhua;
- Qiu, Lugui
Publication type:
journal article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
By:
- Jiahui, Liu;
- huishou, Fan;
- Xuehan, Mao;
- Yan, yuting;
- Chenxing, Du;
- zengjun, lizengjun;
- Yi, Shuhua;
- Wang, Tingyu;
- Lv, Rui;
- Weiwei, Sui;
- Liu, Wei;
- deng, shuhui;
- Fu, Mingwei;
- Wang, Qi;
- Zou, Dehui;
- Qiu, Lugui;
- An, gang
Publication type:
Article
Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.369
By:
- Weiwei, Sui;
- deng, shuhui;
- An, gang;
- Xu, Yan;
- hao, mu;
- Mao, xuehan;
- Zou, De-Hui;
- Qiu, Lugui
Publication type:
Article
The prognostic impact of dynamic changing of cytogenetic abnormalities under the treatment options in multiple myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e221, doi. 10.1016/j.clml.2019.09.368
By:
- huishou, Fan;
- Jiahui, Liu;
- Xuehan, Mao;
- zengjun, lizengjun;
- Weiwei, Sui;
- Chenxing, Du;
- deng, shuhui;
- Wang, Tingyu;
- Yan, yuting;
- Qiu, Lugui;
- An, gang
Publication type:
Article
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates the therapy-induced clonal selection in multiple myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e187, doi. 10.1016/j.clml.2019.09.313
By:
- yuting Yan;
- xuehan Mao;
- Fan huishou;
- Jiahui, Liu;
- Du, Chenxing;
- lizengjun zengjun;
- Wang, Tingyu;
- Weiwei, Sui;
- shuhui deng;
- gang An
Publication type:
Article
Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e83, doi. 10.1016/j.clml.2019.09.132
By:
- Mao, xuehan;
- Xu, Yan;
- Yan, yuting;
- Jiahui, Liu;
- huishou, Fan;
- Weiwei, Sui;
- zengjun, lizengjun;
- deng, shuhui;
- Yi, Shuhua;
- Wang, Tingyu;
- Wang, Qi;
- Liu, Hui-Min;
- Qiu, Lugui;
- An, gang
Publication type:
Article
IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e82, doi. 10.1016/j.clml.2019.09.131
By:
- Mao, xuehan;
- Xu, Yan;
- Yan, yuting;
- Jiahui, Liu;
- huishou, Fan;
- Weiwei, Sui;
- zengjun, lizengjun;
- deng, shuhui;
- Yi, Shuhua;
- Wang, Tingyu;
- Wang, Qi;
- Liu, Hui-Min;
- Xiong, Wen-Jie;
- Du, Chenxing;
- hao, mu;
- Qiu, Lugui;
- An, gang
Publication type:
Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
By:
- Du, Chenxing;
- An, gang;
- Xu, Yan;
- Mao, xuehan;
- Jiahui, Liu;
- huishou, Fan;
- Wang, Qi;
- Weiwei, Sui;
- deng, shuhui;
- Fu, Mingwei;
- zengjun, lizengjun;
- Yi, Shuhua;
- Zou, Dehui;
- Qiu, Lugui
Publication type:
Article
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
Published in:
2018
By:
- Xu, Yan;
- Deng, Shuhui;
- Mao, Xuehan;
- An, Gang;
- Li, Zengjun;
- Wang, Yafei;
- Fulciniti, Mariateresa;
- Ho, Matthew;
- Lin, Jianhong;
- Sui, Weiwei;
- Liu, Wei;
- Zou, Dehui;
- Yi, Shuhua;
- Huang, Wenyang;
- Liu, Hong;
- Lv, Rui;
- Li, Jian;
- Wang, Tingyu;
- Du, Chenxing;
- Munshi, Nikhil C.
Publication type:
journal article
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77450-y
By:
- Liu, Lanting;
- Yu, Zhen;
- Cheng, Hui;
- Mao, Xuehan;
- Sui, Weiwei;
- Deng, Shuhui;
- Wei, Xiaojing;
- Lv, Junqiang;
- Du, Chenxing;
- Xu, Jie;
- Huang, Wenyang;
- Xia, Shuang;
- An, Gang;
- Zhou, Wen;
- Ma, Xiaoke;
- Cheng, Tao;
- Qiu, Lugui;
- Hao, Mu
Publication type:
Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
Published in:
Stem Cell Research & Therapy, 2015, v. 6, p. 1, doi. 10.1186/s13287-015-0164-4
By:
- Sidan Li;
- Dehui Zou;
- Changhong Li;
- Hengxing Meng;
- Weiwei Sui;
- Sizhou Feng;
- Tao Cheng;
- Qiongli Zhai;
- Lugui Qiu
Publication type:
Article
Synthesis of Hydrophobic Polymeric Cryogels with Supermacroporous Structure.
Published in:
Macromolecular Materials & Engineering, 2016, v. 301, n. 6, p. 659, doi. 10.1002/mame.201500454
By:
- Chen, Xilu;
- Sui, Weiwei;
- Ren, Dayong;
- Ding, Yuanyuan;
- Zhu, Xiaoli;
- Chen, Zhiyong
Publication type:
Article
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
Published in:
Cancer (0008543X), 2024, v. 130, n. 3, p. 421, doi. 10.1002/cncr.35056
By:
- Yan, Wenqiang;
- Xu, Jingyu;
- Fan, Huishou;
- Li, Lingna;
- Cui, Jian;
- Du, Chenxing;
- Deng, Shuhui;
- Sui, Weiwei;
- Xu, Yan;
- Hao, Mu;
- Anderson, Kenneth C.;
- Zou, Dehui;
- Qiu, Lugui;
- An, Gang
Publication type:
Article

Found: 29